HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thangaselvam Muthusamy Selected Research

Carcinogenesis

10/2018Oncogenic R132 IDH1 Mutations Limit NADPH for De Novo Lipogenesis through (D)2-Hydroxyglutarate Production in Fibrosarcoma Sells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thangaselvam Muthusamy Research Topics

Disease

3Neoplasms (Cancer)
10/2022 - 10/2018
2Fibrosarcoma
11/2018 - 10/2018
1Hereditary Sensory and Autonomic Neuropathies (HSAN)
10/2022
1Carcinogenesis
10/2018

Drug/Important Bio-Agent (IBA)

2Alanine (L-Alanine)FDA Link
10/2022 - 10/2020
2Serine (L-Serine)FDA Link
10/2022 - 10/2020
2NADP (NADPH)IBA
11/2018 - 10/2018
11-deoxysphingolipidIBA
10/2022
1IsotopesIBA
10/2022
1SphingolipidsIBA
10/2020
1Serine C-PalmitoyltransferaseIBA
10/2020
1Oxidoreductases (Dehydrogenase)IBA
10/2018
1isocitric acid (isocitrate)IBA
10/2018